Grifols stock: buy or sell?
May 22nd, 2020
Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally.
Should I buy Grifols stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Grifols stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Grifols stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for GRFS stock for the last month.
Grifols stock analysis
Grifols closed on Friday at $20.61 and depreciated a disappointing -0.91%.
Grifols shares depreciated -0.91% to $20.61 on Friday. Since last March when GRFS stock price broke down the SMA200d line, it slid $-1.51 per share (-6.83%). On February, GRFS hit new all time highs, pushing higher previous ATH of $25.42 recorded on February. New ATHs are usual entry points for many trading setups as there aren't higher resistences.
After sliding for 4 weeks, last week Grifols rocketed an exceptional 6.73%, closing at $20.61. Late March GRFS plunged a dreadful -7.66% in just one week. After 4 weeks sliding, last week raised a 6.58%.
Weekly chart tells us that price is in a simple uptrend, tested $17.72 level and now climbing back aiming its last top at $21.88. Not so far away is the last price record Grifols marked by mid February, but since then it dropped a 19.90%.
Grifols stock price history
Grifols IPO was on June 2nd, 2011 at $6.49 per share1. Since then, GRFS stock surged a 217.60%, with a yearly average of 27.20%. If you had invested right after GRFS's IPO a $1,000 in Grifols stock in 2011, it would worth $2,176.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Grifols stock historical price chart
GRFS stock reached all-time highs on February with a price of $25.73.
Grifols stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price forecast for Grifols stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, when Grifols posted its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Grifols annual turnover grew a decent 3.91% to $4,486.72 million dollars from $4,318.07 marked in 2017. Nonetheless, its income margin (compared to revenues) slightly fell to 13.30%, that is $596.64 million.
|2013||$2,740 M||-||$346 M12.6%||-|
|2014||$3,355 M||22.46%||$470 M14.0%||36.09%|
|2015||$3,935 M||17.26%||$532 M13.5%||13.16%|
|2016||$4,050 M||2.93%||$545 M13.5%||2.50%|
|2017||$4,318 M||6.62%||$663 M15.3%||21.49%|
|2018||$4,487 M||3.91%||$597 M13.3%||-9.97%|
Quarterly financial resultsGrifols posted $1,222.81 million in revenues for 2018-Q4, a 6.91% up compared to previous quarter. Reported quarter income marked $128.35 million with a profit margin of 10.50%. Profit margin decreased a -2.56% compared to previous quarter when profit margin was 13.05%. When comparing revenues to same quarter last year, Grifols sales marked an outstanding growth and boosted a 14.51%. Looking back to recent quarterly results, Grifols posted 3 positive quarters in a row.
|2017-Q1||$1,131 M||-||$143 M12.6%||-|
|2017-Q2||$1,292 M||14.20%||$164 M12.7%||15.12%|
|2017-Q3||$1,060 M||-17.95%||$154 M14.5%||-6.37%|
|2017-Q4||$1,068 M||0.74%||$231 M21.6%||50.06%|
|2018-Q1||$1,023 M||-4.20%||$143 M14.0%||-37.90%|
|2018-Q2||$1,097 M||7.24%||$176 M16.0%||22.43%|
|2018-Q3||$1,144 M||4.26%||$149 M13.1%||-14.95%|
|2018-Q4||$1,223 M||6.91%||$128 M10.5%||-14.05%|
Grifols ownershipReviewing Grifols ownership structure gives valuable information about the company and its governance (insider ownership) or the amount of investors that are on the short side.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Grifols, 0.00% of all outstanding shares are owned by its staff.
In case of Grifols stock, 53.68% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for GRFS stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Grifols:
|Market cap||$14.1 B|
|Total shares||684.1 M|
|Float shares||1,110.0 M|
|- Institutional holdings (%)||53.7%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Friday, May 22nd, 2020|
|Day range||$20.37 - $20.89|
|Average true range||$0.77|
|50d mov avg||$19.74|
|100d mov avg||$21.58|
|200d mov avg||$21.46|
Grifols performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We picked as the bechmarking frame for Grifols stock.